Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

Clinical trial NCT06518564 · RECRUITING

Trial details

NCT number: NCT06518564
Sponsor: Panagiotis Konstantinopoulos, MD, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer ARID1A Gene Mutation Recurrent Endometrial Carcinoma

Start date: 2024-11-14
Primary completion: 2027-08-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.